Evidence map›Paper›PMID 27023170›Full record

ArticleTranslational psychiatry2016

Whole-exome sequencing in obsessive-compulsive disorder identifies rare mutations in immunological and neurodevelopmental pathways.

C Cappi, H Brentani, L Lima, S J Sanders, G Zai, B J Diniz, V N S Reis, A G Hounie, M Conceição do Rosário, D Mariani and 7 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Serotonin 5-HTPsychopharmacology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

C CappiDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
H BrentaniDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
L LimaDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
S J SandersDepartment of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.
G ZaiNeurogenetics Section, Centre for Addiction and Mental Health, Institute of Medical Science and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
B J DinizDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
V N S ReisDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
A G HounieDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
M Conceição do RosárioFederal University of São Paulo-UPIA-UNIFESP, São Paulo, Brazil.
D MarianiDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
G L RequenaDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
R PugaDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
F L Souza-DuranDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
R G ShavittDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
D L PaulsDepartment of Psychiatry, Harvard Medical School, Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetics Research, Massachusetts General Hospital, Boston, MA, USA.
E C MiguelDepartment of Psychiatry, University of São Paulo School of Medicine, Ovideo Pires de Campos, São Paulo, Brazil.
T V FernandezChild Study Center and Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Universidade de São Paulo · BRMassachusetts General Hospital · USUniversidade Federal de São Paulo · BRUniversity of California, San Francisco · USUniversity of Toronto · CAYale University · US

Funding

Genomic Investigations of Tourette's DisorderK08MH099424 · NIMH · YALE UNIVERSITY · PI FERNANDEZ, THOMAS V · 2012 to 2015
$718k
NIMH NIH HHS K08 MH099424NIMH NIH HHS L40 MH081784
6 · The paper itself

Abstract

Studies of rare genetic variation have identified molecular pathways conferring risk for developmental neuropsychiatric disorders. To date, no published whole-exome sequencing studies have been reported in obsessive-compulsive disorder (OCD). We sequenced all the genome coding regions in 20 sporadic OCD cases and their unaffected parents to identify rare de novo (DN) single-nucleotide variants (SNVs). The primary aim of this pilot study was to determine whether DN variation contributes to OCD risk. To this aim, we evaluated whether there is an elevated rate of DN mutations in OCD, which would justify this approach toward gene discovery in larger studies of the disorder. Furthermore, to explore functional molecular correlations among genes with nonsynonymous DN SNVs in OCD probands, a protein-protein interaction (PPI) network was generated based on databases of direct molecular interactions. We applied Degree-Aware Disease Gene Prioritization (DADA) to rank the PPI network genes based on their relatedness to a set of OCD candidate genes from two OCD genome-wide association studies (Stewart et al., 2013; Mattheisen et al., 2014). In addition, we performed a pathway analysis with genes from the PPI network. The rate of DN SNVs in OCD was 2.51 × 10(-8) per base per generation, significantly higher than a previous estimated rate in unaffected subjects using the same sequencing platform and analytic pipeline. Several genes harboring DN SNVs in OCD were highly interconnected in the PPI network and ranked high in the DADA analysis. Nearly all the DN SNVs in this study are in genes expressed in the human brain, and a pathway analysis revealed enrichment in immunological and central nervous system functioning and development. The results of this pilot study indicate that further investigation of DN variation in larger OCD cohorts is warranted to identify specific risk genes and to confirm our preliminary finding with regard to PPI network enrichment for particular biological pathways and functions.

Indexed as

AdolescentCase-Control StudiesChildExomeFamilyFemaleHumansImmune System PhenomenaMaleMutationNervous SystemObsessive-Compulsive DisorderPilot ProjectsPolymorphism, Single NucleotideProtein Interaction MapsSequence Analysis, DNA

Identifiers

PMID27023170
PMCPMC4872454
OpenAlexW2333128705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.